Compound Summary
N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide
Compound Information
N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide
Compound Name: | N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide |
Compound CID: | 3626837 |
Synonyms: | N-(2-4-(4-Chlorophenyl)piperazin-1-ylethyl)-3-methoxybenzamide CHEMBL93403 N-2-(4-(4-Chlorophenyl)piperazin-1-yl)ethyl-3-methoxybenzamide N-2-4-(4-chlorophenyl)piperazin-1-ylethyl-3-methoxybenzamide n-(2-(4-(4-chlorophenyl)piperazin-1-yl)ethyl)-3-methoxybenzamide More... |
Iupac Name: | N-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide |
InChI: | InChI=1S/C20H24ClN3O2/c1-26-19-4-2-3-16(15-19)20(25)22-9-10-23-11-13-24(14-12-23)18-7-5-17(21)6-8-18/h2-8,15H,9-14H2,1H3,(H,22,25) |
InChIKey: | DQVARXSGNFBPMB-UHFFFAOYSA-N |
Canonical Smiles: | COC1=CC=CC(=C1)C(=O)NCCN2CCN(CC2)C3=CC=C(C=C3)Cl |
Isomeric Smiles: | COC1=CC=CC(=C1)C(=O)NCCN2CCN(CC2)C3=CC=C(C=C3)Cl |
Molecular Weight: | 373.9 |
Molecular Formula: | C20H24ClN3O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide
Molecular Weight: | 373.9 |
Molecular Formula: | C20H24ClN3O2 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 6 |
Heavy Atom Count: | 26 |
Complexity: | 435 |
Synonyms
N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide
| N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide | N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide |
|---|---|
N-(2-4-(4-Chlorophenyl)piperazin-1-ylethyl)-3-methoxybenzamide |
CHEMBL93403 |
N-2-(4-(4-Chlorophenyl)piperazin-1-yl)ethyl-3-methoxybenzamide |
N-2-4-(4-chlorophenyl)piperazin-1-ylethyl-3-methoxybenzamide |
n-(2-(4-(4-chlorophenyl)piperazin-1-yl)ethyl)-3-methoxybenzamide |
Lopac-C-7230 |
Lopac0_000287 |
MLS002153518 |
SCHEMBL1322020 |
DTXSID301017677 |
HMS2230B03 |
HMS3260J16 |
HMS3373J10 |
PB-12 |
Tox21_500287 |
BDBM50068366 |
CCG-204382 |
LP00287 |
SDCCGSBI-0050275.P002 |
NCGC00015262-01 |
NCGC00015262-02 |
NCGC00015262-03 |
NCGC00015262-04 |
NCGC00093740-01 |
NCGC00093740-02 |
NCGC00260972-01 |
SMR001230850 |
EU-0100287 |
C 7230 |
SR-01000075777 |
SR-01000075777-1 |
F5264-0494 |
N-{2-4-(4-Chloro-phenyl)-piperazin-1-yl-ethyl}-3-methoxy-benzamide |
219125-63-0 |
Experimental Data
N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 29.000000000000000 | NS | N2 | 24134630 | Inactive | ||||||
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 35.000000000000000 | S | N2 | 24134630 | Active | ||||||
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 35.000000000000000 | S | N2 | 33683565 | Active |
Experimental Data Visualization
N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide
Statistics Data
N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 35.000000000000000 | 2 | 3 |
Statistics Data Visualization
N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide
